# Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain

> **NCT07451431** · PHASE4 · RECRUITING · sponsor: **Bangladesh Medical University** · enrollment: 78 (estimated)

## Conditions studied

- Diabetic Peripheral Neuropathic Pain (DPNP)

## Interventions

- **DRUG:** Mirogabalin
- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT07451431
- **Lead sponsor:** Bangladesh Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-03
- **Final completion:** 2027-05
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07451431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07451431, "Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07451431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*